PREVENT-E4: 2 g/day DHA did not slow cognitive decline in 365 at-risk older adults
Louis reports the PREVENT-E4 randomized trial found no cognitive or hippocampal-volume difference between DHA and placebo over two years, though it showed 2 g DHA reached spinal fluid equally in APOE4 carriers and non-carriers. The trial was small and designed mainly to test brain penetration.
